nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absorption, Distribution, Metabolism, and Excretion (ADME) Studies of Biotherapeutics for Autoimmune and Inflammatory Conditions
|
Vugmeyster, Yulia |
|
2012 |
14 |
4 |
p. 714-727 |
artikel |
2 |
ADME of Antibody–Maytansinoid Conjugates
|
Erickson, Hans K. |
|
2012 |
14 |
4 |
p. 799-805 |
artikel |
3 |
A One-Step Solid Phase Extraction Method for Bioanalysis of a Phosphorothioate Oligonucleotide and Its 3′ n-1 Metabolite from Rat Plasma by uHPLC–MS/MS
|
Chen, Buyun |
|
2012 |
14 |
4 |
p. 772-780 |
artikel |
4 |
Bioequivalence Requirements in the European Union: Critical Discussion
|
García-Arieta, Alfredo |
|
2012 |
14 |
4 |
p. 738-748 |
artikel |
5 |
Challenges and Opportunities in Absorption, Distribution, Metabolism, and Excretion Studies of Therapeutic Biologics
|
Xu, Xin |
|
2012 |
14 |
4 |
p. 781-791 |
artikel |
6 |
Characterising Lipid Lipolysis and Its Implication in Lipid-Based Formulation Development
|
Thomas, Nicky |
|
2012 |
14 |
4 |
p. 860-871 |
artikel |
7 |
Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs
|
Gao, Ping |
|
2012 |
14 |
4 |
p. 703-713 |
artikel |
8 |
Crystalline Nanosuspensions as Potential Toxicology and Clinical Oral Formulations for BCS II/IV Compounds
|
Kesisoglou, Filippos |
|
2012 |
14 |
4 |
p. 677-687 |
artikel |
9 |
Drug Repurposing: Far Beyond New Targets for Old Drugs
|
Oprea, T. I. |
|
2012 |
14 |
4 |
p. 759-763 |
artikel |
10 |
Effective Absorption Modeling in Relative Bioavailability Study Risk Assessment
|
Rose, John P. |
|
2012 |
14 |
4 |
p. 895-903 |
artikel |
11 |
Effect of Device Design on the In Vitro Performance and Comparability for Capsule-Based Dry Powder Inhalers
|
Shur, Jagdeep |
|
2012 |
14 |
4 |
p. 667-676 |
artikel |
12 |
Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?
|
Diab, Roudayna |
|
2012 |
14 |
4 |
p. 688-702 |
artikel |
13 |
Evaluation of a Catenary PBPK Model for Predicting the In Vivo Disposition of mAbs Engineered for High-Affinity Binding to FcRn
|
Chen, Yang |
|
2012 |
14 |
4 |
p. 850-859 |
artikel |
14 |
Evaluation of an Innovative Population Pharmacokinetic-Based Design for Behavioral Pharmacodynamic Endpoints
|
Viberg, Anders |
|
2012 |
14 |
4 |
p. 657-663 |
artikel |
15 |
Functional and Molecular Aspects of Biotin Uptake via SMVT in Human Corneal Epithelial (HCEC) and Retinal Pigment Epithelial (D407) Cells
|
Vadlapudi, Aswani Dutt |
|
2012 |
14 |
4 |
p. 832-842 |
artikel |
16 |
Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective
|
Bonate, P. L. |
|
2012 |
14 |
4 |
p. 749-758 |
artikel |
17 |
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration
|
Davit, Barbara M. |
|
2012 |
14 |
4 |
p. 915-924 |
artikel |
18 |
International Veterinary Bioequivalence Guideline Similarities and Differences Between Australia, Canada, Europe, Japan, New Zealand and the United States
|
Lainesse, Chantal |
|
2012 |
14 |
4 |
p. 792-798 |
artikel |
19 |
Metrics for the Evaluation of Bioequivalence of Modified-Release Formulations
|
Endrenyi, Laszlo |
|
2012 |
14 |
4 |
p. 813-819 |
artikel |
20 |
Monoamine Transporter Structure, Function, Dynamics, and Drug Discovery: A Computational Perspective
|
Manepalli, Sankar |
|
2012 |
14 |
4 |
p. 820-831 |
artikel |
21 |
Pharmacokinetics and Tissue Disposition of Lenalidomide in Mice
|
Rozewski, Darlene M. |
|
2012 |
14 |
4 |
p. 872-882 |
artikel |
22 |
Phosphorothioate Oligonucleotide Quantification by μ-Liquid Chromatography-Mass Spectrometry
|
Erb, Robert |
|
2012 |
14 |
4 |
p. 728-737 |
artikel |
23 |
Rationalizing Structure and Target Relationships between Current Drugs
|
Hu, Ye |
|
2012 |
14 |
4 |
p. 764-771 |
artikel |
24 |
Regulatory Pathways for ATP-binding Cassette Transport Proteins in Kidney Proximal Tubules
|
Masereeuw, Rosalinde |
|
2012 |
14 |
4 |
p. 883-894 |
artikel |
25 |
Semi-mechanistic Modeling of the Interaction Between the Central and Peripheral Effects in the Antinociceptive Response to Lumiracoxib in Rats
|
Vélez de Mendizábal, Nieves |
|
2012 |
14 |
4 |
p. 904-914 |
artikel |
26 |
Shrinkage in Nonlinear Mixed-Effects Population Models: Quantification, Influencing Factors, and Impact
|
Xu, Xu Steven |
|
2012 |
14 |
4 |
p. 927-936 |
artikel |
27 |
Statistics on BCS Classification of Generic Drug Products Approved Between 2000 and 2011 in the USA
|
Nair, Anil K. |
|
2012 |
14 |
4 |
p. 664-666 |
artikel |
28 |
Universal Immunoassay Applied During Early Development of Large Molecules to Understand Impact of Immunogenicity on Biotherapeutic Exposure
|
Bautista, Ami C. |
|
2012 |
14 |
4 |
p. 843-849 |
artikel |
29 |
Use of Partial Area under the Curve Metrics to Assess Bioequivalence of Methylphenidate Multiphasic Modified Release Formulations
|
Stier, Ethan M. |
|
2012 |
14 |
4 |
p. 925-926 |
artikel |
30 |
Variation of Stratum Corneum Biophysical and Molecular Properties with Anatomic Site
|
Mohammed, Diar |
|
2012 |
14 |
4 |
p. 806-812 |
artikel |